相关实验视频

Updated: Jul 16, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

单酸脂A组装的纳米疫苗可以增强瘤免疫疗法

Rui Li¹, Yuhao Hao¹, Wen Pan¹

¹Department of Chemistry, University of Science and Technology of China, Hefei, 230026, China.

Acta biomaterialia

|September 14, 2023

概括

使用单脂A (MPLA) 和瘤抗原的最小成分癌症纳米疫苗 (MAN) 可以增强抗瘤免疫力. 将MAN与αPD-1疗法的结合有效地改变了瘤的免疫微环境,并改善了治疗结果.

科学领域:

免疫学免疫学免疫学
纳米技术纳米技术
在瘤学瘤学.

背景情况:

治疗癌症的纳米疫苗看起来有前途,但在免疫性和纳米载体安全性方面面临挑战.
现有的纳米疫苗往往具有复杂的成分,阻碍了临床转化.

研究的目的:

开发最小组件癌症纳米疫苗 (MANs) 以提高临床适用性.
评估MANs在激活抗瘤免疫反应和增强免疫疗法的有效性.

主要方法:

使用化学疗法诱导的瘤细胞和单酸脂A (MPLA) 的蛋白质抗原来构建MAN.
这项研究分析了MANs激活托尔类受体4 (TLR4) 信号传递,促进DC和T细胞激活,调节瘤免疫微环境 (TIME) 的能力.
在CT26结直肠癌模型中评估了疗效,评估了MANs与αPD-1疗法相结合.

主要成果:

MANs有效地激活了TLR4通路,并促进了对瘤抗原的适应性免疫力.
MANs增强了树突细胞 (DC) 的抗原捕获,并促进了DC和T细胞的激活.
曼和αPD-1的组合通过将TIME从"冷"转换为"热"并促进免疫细胞透,显著提高了治疗疗效.

结论:

MANs代表了一个有前途的策略,用于设计简化的癌症纳米疫苗,以提高临床潜力.
曼斯+αPD-1组合疗法显示出协同效应,为结直肠癌提供了潜在的新治疗方案.

关键词:

化学疗法诱导的抗原.免疫检查点阻断剂免疫检查点阻断剂治疗性的纳米疫苗.收费类受体4的激动剂.瘤的免疫微环境

更多相关视频

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...